We Re A Biotechnology Company On A Mission To Develop Therapies That Will Get Patients With A Heart Attack To The Hospital With Open Coronary Arteries We Focus On Developing Pre Hospital Therapiesbecause Early Action Is Crucial To Preserve Heart Musclethe Longer A Coronary Artery Is Closedthe More Severe The Damage To The Heartstarting Treatment Before Patients Reach The Hospitalsignificantly Improves The Chances Of A Positive Outcome We Re Developing Zalunfibana Promptpotentand Predictable Medication Designed For Treating Patients With A Heart Attack Before They Reach The Hospitalzalunfiban Has The Potential To Fulfil A Significant Unmet Medical Need In The Pre Hospital Phase Of Heart Attack Care We Re Currently Running The Celebrate Triala Pivotal Phase 3 Prospectiveblindedrandomizedplacebo Controlledinternationalmulticenterstudy Designed To Assess The Safety And Efficacy Of A Single Subcutaneous Injection Of Zalunfiban In Patients With St Segment Elevation Myocardial Infarction In The Pre Hospital Setting
No conferences found for this company.
| Company Name | Celecor Therapeutics Inc |
| Country |
United States
|
| Address | 1155 Camino Del Mar Suite 481 |
| Telephone | Login to View |
| Login to View |
